It was found that at AFP ≥ 7 ng/mL, 45 cases, or 58.4%, were diagnosed as HCC, but AFP sensitivity decreased to 41.6% at AFP ≥ 100 ng/mL. This evidence concerns the gene AFP and hepatocellular carcinoma.